AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Efoglim MV 2mg/500mg/0.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Oldmed Healthcare Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Efoglim MV 2mg/500mg/0.2mg Tablet SR

Diabetic patients using the combination medication, Efoglim MV 2mg/500mg/0.2mg Extended-Release Tablets, should be aware that it's classified as an antidiabetic agent for managing type 2 diabetes in adults. This formulation helps regulate blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage will be determined and adjusted by your physician based on your blood sugar response. Continuous use is vital; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive treatment plan that includes a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are crucial for diabetes control. Commonly reported is hypoglycemia (low blood sugar). Learn to recognize its symptoms—sweating, dizziness, headache, tremors—and how to manage them. Preventative measures include regular meals and carrying a rapid-acting glucose source (e.g., sugary snacks, fruit juice). Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is also a possibility. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart conditions should inform their physician before commencing treatment. Consult your doctor before use if pregnant or breastfeeding. Regular blood sugar monitoring is essential, and your doctor may order blood tests to track blood cell levels and liver function.

Uses of Efoglim MV 2mg/500mg/0.2mg Tablet SR

Managing type 2 diabetes

Major Benefits of Efoglim MV 2mg/500mg/0.2mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Efoglim MV 2mg/500mg/0.2mg Extended-Release Tablet on an empty stomach.

Common Side effects of Efoglim MV 2mg/500mg/0.2mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Efoglim MV 2mg/500mg/0.2mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Efoglim MV 2mg/500mg/0.2mg Tablet SR whole; do not chew, crush, or divide it. Administer this extended-release tablet on an empty stomach.

How Efoglim MV 2mg/500mg/0.2mg Tablet SR works:

Extended-release Efoglim MV tablets (2mg/500mg/0.2mg) contain a triple combination of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Efoglim MV 2mg/500mg/0.2mg SR Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Efoglim MV 2mg/500mg/0.2mg Extended-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Efoglim MV tablets (2mg/500mg/0.2mg) are likely not safe for use while breastfeeding. Available evidence from humans indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Efoglim MV 2mg/500mg/0.2mg Tablet SR, as its use may be unsafe. Medical advice is recommended. Furthermore, this medication is unsuitable for individuals with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Efoglim MV 2mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Efoglim MV 2mg/500mg/0.2mg Tablet SR :

Should you forget to take your Efoglim MV 2mg/500mg/0.2mg Tablet SR, ingest it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid doubling the prescribed dosage.

Facts to Know About Efoglim MV 2mg/500mg/0.2mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Efoglim MV 2mg/500mg/0.2mg Tablet SR

Efoglim MV 2mg/500mg/0.2mg SR tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose levels. This medication is unsuitable for type 1 DM.
Efoglim MV 2mg/500mg/0.2mg SR tablets may cause common side effects including low blood sugar, nausea, diarrhea, altered taste, gas, stomach pain, headache, rash, and respiratory infections.
Efoglim MV 2mg/500mg/0.2mg Tablet SR is contraindicated in patients allergic to its components or excipients, those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Efoglim MV 2mg/500mg/0.2mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Efoglim MV 2mg/500mg/0.2mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, as directed on the label. Dispose of any unused medication properly and ensure it's inaccessible to children, pets, and others.
Efoglim MV 2mg/500mg/0.2m...
94
MRP 109
13% off